Singula Bio Analysis: $3M Raised
What is Singula Bio?
Neoantigen-based cell therapies for cancer treatment
HQ Country
Oxford, United Kingdom
Employees
1-10
Founded
2020
HQ State/Province
England
Funding Category
Seed
HQ Full Address
John Radcliffe Hospital, Oxford, England OX3 9DS, United Kingdom
Product Features & Capabilities
- Neoantigen-based cell therapies
- Immunological technologies
- Medical technologies
- Surgical technologies
- Computational technologies
Other Considerations
Founded by experts in cancer medicine and immunology; Team includes experienced professionals in live-cell therapy; Enzo Cerundolo's legacy drives the mission forward
